peptide tirzepatide dosage How Long Does a Vial of Last? At a glance factsheet: Tirzepatide

Tirzepatide has a unique dual action as it activates both GLP-1 and GIP receptors simultaneously, unlike other older drugs that only activate GLP-1 receptors (semaglutide, liraglutide, and dulaglutide)

A higher dose of Wegovy (7.2 mg) has been available in the UK since early 2026, and its average weight-loss outcomes are comparable to that of Mounjaro 15 mg

It is also important to note that tirzepatide is not recommended for everyone and should be used under the guidance of a healthcare professional

the weight loss in the medium-dose (10mg) group was 19.5%, with a weight loss of approximately 20.9 kg

Friendly staff, great follow up and judgement free zone

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial